GlassScriptPhysician profile
Ashley Cote
NPI 1255710760
$1,614.31
in general payments reported to CMS, 2019-2025
15 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $150 · 2022: $365 · 2023: $197 · 2024: $639 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656 · Travel and Lodging: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.76 |
| Travel and Lodging | $443.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $516.70 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $278.87 | 2022-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Sanofi-Aventis U.S. LLC | $163.76 | 2025 | |
| Sanofi Pasteur INC. | $132.92 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $125.00 | 2021 | |
| Incyte Corporation | $115.64 | 2024 | Opzelura |
| Phadia US INC. | $57.72 | 2024-2025 | Immunocap |
| Pfizer INC. | $53.47 | 2023-2025 | |
| Medtronic, INC. | $30.31 | 2022 | |
| Alkermes, INC. | $26.89 | 2023 | Vivitrol |
| Vyne Pharmaceuticals INC. | $25.47 | 2021 | |
| Glaxosmithkline, LLC. | $25.13 | 2024 | Arexvy, Shingrix |
| Abbvie INC. | $24.07 | 2025 | |
| Philips North America LLC | $20.84 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Cote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.